CHEK1 and B-cell non-Hodgkin lymphoma: A previous preclinical study investigating the role of Chk1 expression in MYC amplified tumours has in fact shown that its blockade resulted in caspase-depended apoptosis of the MYC-overexpressing tumours cells both in vitro and in murine models of B-cell lymphoma [22].